Related Experiment Video
Updated: Dec 6, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Controlling the thickness of the atherosclerotic plaque by statin medication
Dorota Formanowicz1, Jacek B Krawczyk2
1Department of Clinical Biochemistry and Laboratory Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Abstract:
Atherosclerosis, a chronic inflammatory disorder of the arterial wall, is a complex process whose dynamics are affected by multiple factors. The disease control consists of restraining it by administering statins. Slowing down or halting the plaque growth depends on the patient age at which the statin treatment begins and on the thickness of the intima-media (IMT) at that time. In this paper, we propose a mathematical model to estimate the sets of atherosclerosis states, from which the use of statins can restrain the disease. Our model is control-theoretic, and the estimated sets are the viability kernels, in the parlance of viability theory. To our best knowledge, this way of modelling the atherosclerosis progression is original. We compute two viability kernels, each for a different statin-treatment dose. Each kernel is composed of the vector [age, IMT] from which the disease can be restrained. By extension, the disease can't be restrained from the kernel complements, this being mainly because of the disease and patient-age advancement. The kernels visualise tradeoffs between early and late treatments, which helps the clinician to decide when to start the statin treatment and which statin dose may be sufficient.
Insights
This study introduces a novel mathematical model for atherosclerosis, identifying optimal statin treatment timing and dosage based on patient age and intima-media thickness (IMT). The model visualizes treatment viability kernels to guide clinical decisions.
Area of Science:
- Cardiovascular Medicine
- Mathematical Biology
- Control Theory
Background:
- Atherosclerosis is a complex, chronic inflammatory arterial disease influenced by multiple factors.
- Current disease management relies on statin therapy to control plaque progression.
- Treatment effectiveness is contingent on the patient's age and intima-media thickness (IMT) at the initiation of statin therapy.
Purpose of the Study:
- To develop a novel control-theoretic mathematical model for estimating atherosclerosis states.
- To identify the 'viability kernels' representing conditions under which statin therapy can effectively restrain disease progression.
- To provide clinicians with a tool to optimize statin treatment initiation and dosage.
Main Methods:
- Application of control-theoretic principles to model atherosclerosis dynamics.
- Computation of viability kernels, representing sets of [age, IMT] states from which disease progression is controllable.
- Modeling was performed for two different statin treatment doses.
Main Results:
- Two distinct viability kernels were computed, each corresponding to a specific statin dose.
- These kernels define the [age, IMT] ranges where statin treatment is effective in restraining atherosclerosis.
- The study highlights that beyond these kernels, disease and age advancement limit treatment efficacy.
Conclusions:
- The developed mathematical model offers an original approach to understanding and managing atherosclerosis.
- Viability kernels visually represent the trade-offs between early and late statin treatment initiation.
- The findings aid clinicians in making informed decisions regarding the optimal timing and dosage of statin therapy for atherosclerosis control.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Inflammation
